In addition to cDC1s, which orchestrate the cross-talk between CD4 and CD8 T cells to achieve a potent T cell response, plasmacytoid dendritic cells (pDCs) are emerging as important regulators of anti-tumor responses. This evidence concerns the gene CD4 and neoplasm.